Priapism

Priapism
Name	Priapism
Field	Urology, Emergency medicine
Complications	Erectile dysfunction, Penile fibrosis, Penile gangrene
Types	Ischemic, non-ischemic, stuttering
Causes	Sickle cell disease, Leukemia, Spinal cord injury, Intracavernosal injection
Risks	Hematological malignancy, Pelvic trauma, Substance abuse
Diagnosis	Medical history, Physical examination, Blood gas analysis
Differential	Penile erection, Penile fracture
Treatment	Corporal aspiration, Intracavernosal phenylephrine, Surgical shunt

Priapism. It is a urological emergency characterized by a persistent, often painful, penile erection unrelated to sexual stimulation. The condition is broadly classified into ischemic and non-ischemic types, with a third, recurrent form known as stuttering priapism. Prompt diagnosis and management are critical to prevent permanent tissue damage and long-term complications such as erectile dysfunction.

Definition and classification

The condition is defined as an erection lasting more than four hours. Ischemic priapism, the most common form, is a low-flow state resulting from obstructed venous outflow, leading to hypoxia and acidosis within the Corpora cavernosa penis. Non-ischemic priapism, a high-flow state, is typically caused by unregulated arterial inflow, often due to trauma. Stuttering priapism refers to recurrent, self-limiting episodes commonly associated with Sickle cell disease and certain Hematological disorders.

Causes and pathophysiology

Ischemic priapism is frequently linked to hematologic dyscrasias, with Sickle cell disease being a predominant cause, as sickled red blood cells obstruct venous sinusoids. Pharmacologic triggers include Intracavernosal injection therapy for Erectile dysfunction using agents like Alprostadil or Papaverine. Other causes encompass Leukemia, Multiple myeloma, and the use of Antipsychotic medications or Anticoagulant drugs. Non-ischemic priapism usually follows Pelvic trauma or Perineal injury that creates an arteriocavernous fistula, as seen after incidents like a straddle injury. Neurological causes include Spinal cord injury and conditions affecting the Central nervous system.

Diagnosis and evaluation

Diagnosis begins with a detailed Medical history and Physical examination. A key diagnostic step is Blood gas analysis of blood aspirated from the Corpora cavernosa penis; ischemic priapism shows hypoxic, acidotic, and hypercarbic blood. Color Doppler ultrasonography is the imaging modality of choice to assess blood flow, distinguishing between low-flow and high-flow states. Laboratory evaluation often includes a Complete blood count to screen for Sickle cell disease or Leukemia, and a Toxicology screen for substances like Cocaine or Phosphodiesterase type 5 inhibitor use. The evaluation must also consider differential diagnoses such as Penile fracture.

Management and treatment

For ischemic priapism, first-line treatment involves Corporal aspiration followed by Intracavernosal injection of an alpha-adrenergic agonist like Phenylephrine. If pharmacologic intervention fails, surgical management with a Distal shunt (e.g., Winter shunt) or Proximal shunt is required. Management of non-ischemic priapism is often conservative initially, with observation; selective Arterial embolization may be performed for persistent cases. Stuttering priapism may be managed with oral agents like Gonadotropin-releasing hormone agonist or Beta-2 adrenergic agonist therapies. Underlying conditions, such as a Hematological malignancy, must be treated concurrently.

Prognosis and complications

The prognosis is heavily dependent on the duration of ischemia. Prolonged ischemic priapism can lead to Penile fibrosis and permanent Erectile dysfunction due to corporal smooth muscle necrosis. Other severe complications include Penile gangrene and infection. Even with timely treatment, a significant proportion of patients experience some degree of long-term erectile impairment. Successful management of non-ischemic priapism generally carries a better prognosis for erectile function.

Epidemiology and risk factors

The condition is relatively rare. The highest incidence is observed in males with Sickle cell disease, where the lifetime risk is significant. Other major risk factors include hematologic malignancies like Leukemia, the use of Intracavernosal injection therapy, and a history of Pelvic trauma or Spinal cord injury. Certain psychiatric medications, particularly Trazodone and Antipsychotic drugs, are also associated with increased risk. The epidemiology varies by etiology, with ischemic priapism being more common in clinical practice.

Category:Urological conditions Category:Medical emergencies